title: Glycolytic buffering affects cardiac bioenergetic signaling and contractile reserve similar to creatine kinase.
abstract: Creatine kinase (CK) and glycolysis represent important energy-buffering processes in the cardiac myocyte. Although the role of compartmentalized CK in energy transfer has been investigated intensely, similar duties for intracellular glycolysis have not been demonstrated. By measuring the response time of mitochondrial oxygen consumption to dynamic workload jumps (tmito) in isolated rabbit hearts, we studied the effect of inhibiting energetic systems (CK and/or glycolysis) on transcytosolic signal transduction that couples cytosolic ATP hydrolysis to activation of oxidative phosphorylation. Tyrode-perfused hearts were exposed to 15 min of the following: 1) 0.4 mM iodoacetamide (IA; n = 6) to block CK (CK activity <3% vs. control), 2) 0.3 mM iodoacetic acid (IAA; n = 5) to inhibit glycolysis (GAPDH activity <3% vs. control), or 3) vehicle (control, n = 7) at 37 degrees C. Pretreatment tmito was similar across groups at 4.3 +/- 0.3 s (means +/- SE). No change in tmito was observed in control hearts; however, in IAA- and IA-treated hearts, tmito decreased by 15 +/- 3% and 40 +/- 5%, respectively (P < 0.05 vs. control), indicating quicker energy supply-demand signaling in the absence of ADP/ATP buffering by CK or glycolysis. The faster response times in IAA and IA groups were independent of the size of the workload jump, and the increase in myocardial oxygen consumption during workload steps was unaffected by CK or glycolysis blockade. Contractile function was compromised by IAA and IA treatment versus control, with contractile reserve (defined as increase in rate-pressure product during a standard heart rate jump) reduced to 80 +/- 8% and 80 +/- 10% of baseline, respectively (P < 0.05 vs. control), and significant elevations in end-diastolic pressure, suggesting raised ADP concentration. These results demonstrate that buffering of phosphate metabolites by glycolysis in the cytosol contributes appreciably to slower mitochondrial activation and may enhance contractile efficiency during increased cardiac workloads. Glycolysis may therefore play a role similar to CK in heart muscle.
authors.affiliation: Heart Foundation Research Centre, Griffith University, Gold Coast, Queensland 9726, Australia.
authors.forename: Glenn J
authors.initials: GJ
authors.lastname: Harrison
authors.forename: Michiel H
authors.initials: MH
authors.lastname: van Wijhe
authors.forename: Bas
authors.initials: B
authors.lastname: de Groot
authors.forename: Francina J
authors.initials: FJ
authors.lastname: Dijk
authors.forename: Lori A
authors.initials: LA
authors.lastname: Gustafson
authors.forename: Johannes H G M
authors.initials: JH
authors.lastname: van Beek
mesh_terms: D000818:Animals; D002021:Buffers; D003402:Creatine Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006019:Glycolysis / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D007460:Iodoacetamide / Q000494:pharmacology; D019807:Iodoacetic Acid / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D011817:Rabbits; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
chemical_list: D002021:Buffers; D004791:Enzyme Inhibitors; D003402:Creatine Kinase; D019807:Iodoacetic Acid; D007460:Iodoacetamide